Clinical Trial Update: Open Label, Continuation Study of Cholic Acid in Subjects With Inborn Errors of Bile Acid Synthesis [Phase 3]

View source ↗

Summary

Open-label continuation study of cholic acid in subjects with inborn errors of bile acid synthesis completed; results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bile Acid Synthesis Defect

Drugs mentioned

• Cholic acid (cholic acid)

Snippet

Sponsor: Mirum Pharmaceuticals, Inc. | Conditions: Bile Acid Synthesis Defect | Phase 3 | Status: COMPLETED | Results posted: 2020-08-21